FSSAI Suspends Licenses of Several Nutraceutical Companies for Safety Violations
The FSSAI has suspended licenses of multiple nutraceutical companies due to serious violations of food safety standards.

New Delhi, November 16 (Daily Kiran) : The Food Safety and Standards Authority of India (FSSAI) has taken significant action against several nutraceutical manufacturers following serious violations of food safety standards and regulatory guidelines. On November 16, the authority announced the suspension of licenses for multiple companies as part of its ongoing efforts to ensure consumer safety.
In recent months, the FSSAI has intensified its oversight of the nutraceutical sector, conducting inspections of various manufacturing units. During these inspections, numerous breaches related to product manufacturing, labeling, hygiene, and production processes were uncovered.
The FSSAI identified six companies facing regulatory action: Aren Herbals, Aquabliss Life Sciences, Raskam Healthcare, Supercure Biotech, Ambico Ayurvedic Healthcare, and Vedant Remedies.
Aren Herbals was found to have excessive levels of thiamine, vitamin E acetate, copper, selenium, and zinc in its ‘Lyco-Ve Syrup,’ surpassing the recommended dietary allowance for each serving. Additionally, claims made about its ‘Maxford Pain Relief’ product, which suggested it could alleviate knee pain, were unauthorized, and misleading images related to pain relief were used. The inspection also revealed discrepancies in the information provided about plant-based ingredients.
At Aquabliss Life Sciences, inspectors discovered expired raw materials on-site. Moreover, cleanliness and hygiene standards in the production unit were deemed unsatisfactory.
The investigation revealed that Raskam Healthcare was using shilajit in products where this ingredient was not approved. The company also had several deficiencies in maintaining records and documentation.
Supercure Biotech faced serious irregularities, with the FSSAI noting that its ‘Gemcolin 9G Softgel Capsules’ contained biotin levels exceeding permissible limits. Another product marketed as vitamin E softgel capsules was found to contain wheat germ oil instead of actual vitamin E, potentially misleading consumers. Additionally, the presence of unapproved and pathogenic microorganisms was reported in the company’s probiotic products.
Ambico Ayurvedic Healthcare was found to be using expired materials in the production of its nutraceutical products, and there were shortcomings in adhering to hygiene standards.
Vedant Remedies was also cited for using expired materials in the production of flavoring products. The inspection revealed multiple deficiencies in cleanliness, housekeeping, production infrastructure, and testing facilities.
The FSSAI emphasized that consumer safety remains its top priority in the rapidly growing nutraceutical sector. The authority will continue its monitoring and enforcement actions to ensure product quality, adherence to scientific standards, accurate labeling, and transparency in manufacturing processes.



